Related Experiment Video
Updated: May 7, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Discrepancy between body surface area and body composition in cancer
Nicole Stobäus1, Susanne Küpferling, Marie-Luise Lorenz
1a Charité University Medicine Berlin , Department of Gastroenterology, Infectiology and Rheumatology (Section Nutritional Medicine) , Berlin , Germany.
Cytostatic dosing based on body surface area (BSA) may be inaccurate. This study found low fat-free mass (FFM) in cancer patients, impacting mortality risk, especially in women.
Area of Science:
- Oncology
- Body Composition Analysis
- Pharmacokinetics
Background:
- Cytostatic drug dosing commonly relies on body surface area (BSA), potentially overlooking individual body composition.
- Cancer patients may exhibit significant variations in fat-free mass (FFM) independent of their BSA.
Purpose of the Study:
- To evaluate the discrepancy between BSA and FFM in cancer patients.
- To determine the prevalence of low FFM relative to BSA.
- To assess the impact of low FFM on patient outcomes and mortality.
Main Methods:
- Calculated BSA using the DuBois and DuBois formula for 630 cancer patients.
- Assessed FFM using bioelectrical impedance analysis, categorizing patients into low, normal, or high FFM groups within BSA strata.
- Analyzed the relationship between FFM, BSA, and 1-year mortality in chemotherapy patients.
Main Results:
- A notable discrepancy between FFM and BSA was observed.
- 15.7% of patients presented with low FFM, associated with higher BMI, increased fatigue, and reduced functional status.
- Low FFM was a significant predictor of increased 1-year mortality in patients receiving chemotherapy (HR=1.644, P=0.025).
Conclusions:
- BSA is an inadequate surrogate for FFM in cytostatic dose calculation.
- Low FFM is prevalent in cancer patients and negatively impacts clinical outcomes and survival.
- Women are disproportionately affected by low FFM, highlighting a potential need for sex-specific dosing adjustments.
Related Concept Videos
Cancer Survival Analysis
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Self-Discrepancy and Its Effects
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...

